38 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
28650658	54	Potent, Selective, and Cell Active Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor Developed by Structure-Based Virtual Screening and Hit Optimization.	Shandong University
26220519	5	Design and synthesis of new non nucleoside inhibitors of DNMT3A.	Unit£
25406944	20	Targeting DNA methylation with small molecules: what's next?	Cnrs-Pierre Fabre
25032507	43	Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.	University of North Carolina At Chapel Hill
24900829	11	Analogues of the Natural Product Sinefungin as Inhibitors of EHMT1 and EHMT2.	University of Copenhagen
24387159	36	Selective non-nucleoside inhibitors of human DNA methyltransferases active in cancer including in cancer stem cells.	Sapienza University of Rome
23433670	15	Bromo-deaza-SAH: a potent and selective DOT1L inhibitor.	Entremed
23402879	1	Synthetic approaches to DNMT inhibitor SGI-1027 and effects on the U937 leukemia cell line.	Universidade De Vigo
24900432	51	Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2.	TBA
22854677	32	New cytosine derivatives as inhibitors of DNA methylation.	Polish Academy of Sciences
22280363	104	Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets.	Imperial College
22483584	3	Development of rationally designed DNA N6 adenine methyltransferase inhibitors.	University of Southampton
21958292	7	Synthesis and biochemical evaluation ofd(2)-isoxazoline derivatives as DNA methyltransferase 1 inhibitors.	Universit£
20006515	5	Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation.	Deutsches Krebsforschungszentrum
19364644	47	Constrained (l-)-S-adenosyl-l-homocysteine (SAH) analogues as DNA methyltransferase inhibitors.	Methylgene
19362833	41	SAR around (l)-S-adenosyl-l-homocysteine, an inhibitor of human DNA methyltransferase (DNMT) enzymes.	Methylgene
16420053	4	Discovery of two novel, small-molecule inhibitors of DNA methylation.	Polish Academy of Sciences
32435413	19	Structure-Guided Identification of DNMT3B Inhibitors.	Yale University
27485386	27	New small molecule inhibitors of histone methyl transferase DOT1L with a nitrile as a non-traditional replacement for heavy halogen atoms.	University College London
30704813	4	Synthesis of NSC 106084 and NSC 14778 and evaluation of their DNMT inhibitory activity.	Universit£
30753076	20	Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal Structure.	The University of Texas M.D. Anderson Cancer Center
30366254	49	Identification of novel quinazoline derivatives as potent antiplasmodial agents.	Universit£
31627059	29	Discovery of a potent histone deacetylase (HDAC) 3/6 selective dual inhibitor.	National University of Singapore
24328113	9	Synthesis and evaluation of analogues of N-phthaloyl-l-tryptophan (RG108) as inhibitors of DNA methyltransferase 1.	Universit£
30170321	2	Design, synthesis and in vitro anti-Zika virus evaluation of novel Sinefungin derivatives.	Chinese Academy of Medical Sciences and Peking Union Medical College
30145373	22	Identification of novel inhibitors of histone acetyltransferase hMOF through high throughput screening.	Chinese Academy of Sciences
29890830	112	Detailed Exploration around 4-Aminoquinolines Chemical Space to Navigate the Lysine Methyltransferase G9a and DNA Methyltransferase Biological Spaces.	Wuxi Apptec (Tianjin) Co.
29953809	88	Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy.	Universidad De Oviedo-Principado De Asturias
28463515	21	Rational Design of Bisubstrate-Type Analogues as Inhibitors of DNA Methyltransferases in Cancer Cells.	Cnrs-Pierre Fabre Usr3388
27391855	24	Discovery of a Selective Covalent Inhibitor of Lysophospholipase-like 1 (LYPLAL1) as a Tool to Evaluate the Role of this Serine Hydrolase in Metabolism.	Pfizer